USE OF CA-19-9 IN THE EARLY DETECTION OF RECURRENCES IN COLORECTAL-CANCER - COMPARISON WITH CEA

被引：46

作者：

FILELLA, X

MOLINA, R

PIQUE, JM

GARCIAVALDECASAS, JC

GRAU, JJ

NOVELL, F

ASTUDILLO, E

DELACY, A

DANIELS, M

BALLESTA, AM

机构：

[1] HOSP CLIN BARCELONA,DEPT GASTROENTEROL,BARCELONA,SPAIN

[2] HOSP CLIN BARCELONA,DEPT SURG,BARCELONA,SPAIN

[3] HOSP CLIN BARCELONA,DEPT ONCOL,BARCELONA,SPAIN

来源：

TUMOR BIOLOGY | 1994年 / 15卷 / 01期

关键词：

CA; 19-9; CEA; CANCER-ASSOCIATED ANTIGENS; COLORECTAL CANCER; FOLLOW-UP;

D O I：

10.1159/000217867

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The serum levels of CA 19-9 were determined in the follow-up of 370 patients with colorectal cancer and compared with CEA. An increase in CA 19-9 preceded clinical diagnosis of recurrence in 25% of 72 patients. The mean time between the rise in CA 19-9 and clinical diagnosis of relapse was 3.7 months (median 3). Sensitivity of CA 19-9 in the early diagnosis of recurrence was much lower than that obtained for CEA (75%). Only 1 patient had elevated CA 19-9 levels and normal CEA.

引用

页码：1 / 6

页数：6

共 50 条

[1] COMPARISON OF SERUM CA-19-9 AND CEA LEVELS IN A POPULATION AT HIGH-RISK FOR COLORECTAL-CANCER
GOLDBERG, EM
SIMUNOVIC, LM
DRAKE, SL
MUELLER, WF
VERRILL, HL
HYBRIDOMA, 1989, 8 (05): : 569 - 575
[2] CA-19-9 ANTIBODY IN COLORECTAL-CANCER AND SYNCHRONOUS ADENOMATA
AFDHAL, NH
LONG, A
TOBIN, B
TOBBIA, I
ODONOGHUE, DP
GASTROENTEROLOGY, 1985, 88 (05) : 1301 - 1301
[3] THE ROLE OF CEA, TPA AND CA 19-9 IN THE EARLY DETECTION OF RECURRENT COLORECTAL-CANCER
BARILLARI, P
RAMACCIATO, G
DEANGELIS, R
GOZZO, P
AURELLO, P
INDINNIMEO, M
VALABREGA, S
DANGELO, F
FEGIZ, G
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 1989, 4 (04) : 230 - 233
[4] CORRELATION BETWEEN THE LEVELS OF CA-19-9 AND CA-50 IN COLORECTAL-CANCER
VALLEJO, AL
MERRUURRUTIA, MJD
TOTORICAGUENA, AL
CORTAZAR, JCF
MEDICINA CLINICA, 1988, 90 (01): : 42 - 42
[5] A NEW RADIOIMMUNOASSAY DETECTING EARLY STAGES OF COLON CANCER - A COMPARISON WITH CEA, AFP, AND CA-19-9
CHESTER, SJ
MAIMONIS, P
VANZUIDEN, P
FINKLESTEIN, M
BOOKOUT, J
VEZERIDIS, MP
DISEASE MARKERS, 1991, 9 (05) : 265 - 271
[6] SERUM CA-242 IN PANCREATIC-CANCER - COMPARISON WITH CA-19-9 AND CEA
PEZZILLI, R
BILLI, P
PLATE, L
LAUDADIO, M
SPROVIERI, G
ITALIAN JOURNAL OF GASTROENTEROLOGY, 1995, 27 (06): : 296 - 299
[7] COMPARISON OF CA-19-9 AND CARCINOEMBRYONIC ANTIGEN (CEA) LEVELS IN THE SERUM OF PATIENTS WITH COLORECTAL DISEASES
KUUSELA, P
JALANKO, H
ROBERTS, P
SIPPONEN, P
MECKLIN, JP
PITKANEN, R
MAKELA, O
BRITISH JOURNAL OF CANCER, 1984, 49 (02) : 135 - 139
[8] COMPARISON OF THE TUMOR-MARKERS CEA, TPA, AND CA-19-9 IN COLORECTAL-CARCINOMA
PUTZKI, H
STUDENT, A
JABLONSKI, M
HEYMANN, H
CANCER, 1987, 59 (02) : 223 - 226
[9] SIGNIFICANCE OF MEASUREMENT OF A CARBOHYDRATE ANTIGENIC DETERMINANT-19-9 (CA-19-9) FOR MONITORING COLORECTAL-CANCER PATIENTS
TOMODA, H
FURUSAWA, M
JAPANESE JOURNAL OF SURGERY, 1986, 16 (01): : 73 - 75
[10] PREDICTIVE VALUE OF TUMORAL MARKERS (CEA AND CA 19-9) IN COLORECTAL-CANCER
DESAIVE, C
SERVAIS, R
COLLETTE, J
DENIS, D
REGINSTER, JY
FRANCHIMONT, P
ACTA GASTRO-ENTEROLOGICA BELGICA, 1987, 50 (01): : 65 - 78

← 1 2 3 4 5 →